Patents by Inventor Carol Ensinger

Carol Ensinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080004293
    Abstract: The invention is based on the discovery that compounds of Formula I are unexpectedly highly potent and selective inhibitors of the adenosine A1 receptor. Adenosine A1 antagonists can be useful in the prevention and/or treatment of numerous diseases, including cardiac and circulatory disorders, degenerative disorders of the central nervous system, respiratory disorders, and many diseases for which diuretic treatment is suitable.
    Type: Application
    Filed: July 27, 2007
    Publication date: January 3, 2008
    Inventors: Carol Ensinger, James Dowling, Russell Petter, Gnanasambandam Kumaravel
  • Publication number: 20070015732
    Abstract: The invention is based on the discovery that compounds of Formula I are unexpectedly highly potent and selective inhibitors of the adenosine A1 receptor. Adenosine A1 antagonists can be useful in the prevention and/or treatment of numerous diseases, including cardiac and circulatory disorders, degenerative disorders of the central nervous system, respiratory disorders, and many diseases for which diuretic treatment is suitable.
    Type: Application
    Filed: July 13, 2006
    Publication date: January 18, 2007
    Inventors: William Kiesman, Carol Ensinger, Russell Petter, James Dowling, Gnanasambandam Kumaravel, He Chang, Ko Lin
  • Publication number: 20060252730
    Abstract: The invention is based on the discovery that compounds of Formula I are unexpectedly highly potent and selective inhibitors of the adenosine A1 receptor. Adenosine A1 antagonists can be useful in the prevention and/or treatment of numerous diseases, including cardiac and circulatory disorders, degenerative disorders of the central nervous system, respiratory disorders, and many diseases for which diuretic treatment is suitable.
    Type: Application
    Filed: July 10, 2006
    Publication date: November 9, 2006
    Inventors: William Kiesman, Carol Ensinger, Russell Petter, James Dowling, Gnanasambandam Kumaravel, He Xi Chang, Ko Chung Lin
  • Publication number: 20060030553
    Abstract: The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of using them for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. The compounds and pharmaceutical compositions of this invention can be used as therapeutic or prophylactic agents. They are particularly well-suited for treatment of many inflammatory and autoimmune diseases.
    Type: Application
    Filed: September 26, 2005
    Publication date: February 9, 2006
    Inventors: Zhongli Zheng, Carol Ensinger, Steven Adams
  • Publication number: 20050222179
    Abstract: The invention is based on the discovery that compounds of Formula I are unexpectedly highly potent and selective inhibitors of the adenosine A1 receptor. Adenosine A1 antagonists can be useful in the prevention and/or treatment of numerous diseases, including cardiac and circulatory disorders, degenerative disorders of the central nervous system, respiratory disorders, and many diseases for which diuretic treatment is suitable.
    Type: Application
    Filed: May 13, 2005
    Publication date: October 6, 2005
    Inventors: Carol Ensinger, James Dowling, Russell Petter, Gnanasambandam Kumaravel